Pharma Law USA
The only pharma event examining antitrust, IP, fraud, compliance & regulation in one place. Your one-stop shop to dissect the latest legal developments affecting pharma.
Avoid costly fines and disputes. Gain practical strategies and connect with in-house counsel, regulators & top legal minds.
Brought to you by Informa.
Reasons to attend Informa's Pharma Law USA 2024:
Explore currently developing legal challenges for the pharmaceutical industry, from every angle.
Current challenges in pricing:
- Hatch-Waxman Act at 40: Is it Still Fit for Purpose?
- Inflation Reduction Act, “March-in Rights” & Other Developments in Pricing
- Navigating 340B Drug Program Litigation
Patents & IP:
- Hot Topics in Patents including “Orange Book” Cases & Patent Eligibility
- Update on Reverse Payment Settlements
- How are the Courts Approaching Product Hopping?
- Trademark Infringements & False Advertising Cases
Merger control:
- Review of FTC Guidelines & Lessons Learnt from Recent Mergers
Emerging trends:
- Psychedelics as Pharmaceuticals
- The Risks & Opportunities of AI
- IP in Medical Devices
- Biologics & Biosimilars
Prosecutions & compliance:
- AG's Roundtable
- Recent Perspectives on Healthcare Prosecutions
- Compliance: Best Practice
Meet the pharma industry in Boston
Make connections that matter!
- In-house counsel from across the pharma sector
- Private practice lawyers specializing in: life sciences, IP, antitrust, regulatory, fraud/white collar crime and compliance
- Authorities and regulators
- Antitrust economists
![](https://knect365.imgix.net/uploads/Drinks-Reception-Image---Brussels-aa752beae74171dbda796efb76896c11.jpg?auto=format&fit=max)
Connect with the Pharma Industry in Boston:
Join us at the end of Day 1, Tuesday October 8, for a drinks reception to catch up with your peers and make new connections in an informal setting.
Why attend Informa Connect events?
Showcase your firm to future clients:
Showcase your knowledge and expertise to a top level audience from across the pharma sector - including a high proportion of in-house counsel.
Get in touch with Thomas Martins to discuss speaking, branding and exhibition opportunities.
![](https://knect365.imgix.net/uploads/20240424-102132-d1493d2129d49c968231a80dd7ba2cf6.jpg?auto=format&fit=max)